Role of claudins in tumorigenesis.

The family of more than 20 claudin (CLDN) proteins comprises one of the major structural elements within the apical tight junction apparatus, a dynamic cellular nexus for maintenance of a luminal barrier, paracellular transport, and signal transduction. Loss of normal tight junction functions constitutes a hallmark of human carcinomas. CLDN1 may support tumor suppressive functions in tissues such as the brain, where dramatic loss of expression has been demonstrated in glioblastoma multiforme. The role(s) for CLDNs 3 and 4 in tumorigenesis is less clear. CLDN4 appears to be over-expressed in ovarian and pancreatic carcinomas, and this raises the possibility that a unique, potentially non-toxic cancer cell target may be developed through the design of enterotoxin analogues. Future goals include understanding the biochemical and physiological mechanisms that are perturbed as a consequence of CLDN alterations in the progression of solid tumors.

[1]  Kathleen R. Cho,et al.  Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  R. Mrsny,et al.  Oncogenic Raf-1 Disrupts Epithelial Tight Junctions via Downregulation of Occludin , 2000, The Journal of cell biology.

[3]  M. Ozawa,et al.  The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation , 2004, Journal of Cell Science.

[4]  O. Mundigl,et al.  Expression and targeting of the tight junction protein CLDN1 in CLDN1‐negative human breast tumor cells , 2002, Journal of cellular physiology.

[5]  R Macek,et al.  Expression and function of tight junction associated molecules in human breast tumor cells is not affected by the Ras-MEK1 pathway. , 2003, Cellular and molecular biology.

[6]  P. Claude,et al.  FRACTURE FACES OF ZONULAE OCCLUDENTES FROM "TIGHT" AND "LEAKY" EPITHELIA , 1973, The Journal of cell biology.

[7]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[8]  D. Antonetti,et al.  Regulation of tight junctions and loss of barrier function in pathophysiology. , 2004, The international journal of biochemistry & cell biology.

[9]  M. Bissell,et al.  The Organization of Tight Junctions in Epithelia: Implications for Mammary Gland Biology and Breast Tumorigenesis , 2003, Journal of Mammary Gland Biology and Neoplasia.

[10]  W. Foulkes,et al.  Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells , 2002, Oncogene.

[11]  R. Gutiérrez,et al.  Presence of claudins mRNA in the brain. Selective modulation of expression by kindling epilepsy. , 2002, Brain research. Molecular brain research.

[12]  O. Cummings,et al.  Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. , 2001, Cancer research.

[13]  Pedram Argani,et al.  Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. , 2004, The American journal of pathology.

[14]  S. Tsukita,et al.  Expression of claudin‐5 in dermal vascular endothelia , 2003, Experimental dermatology.

[15]  A. Hopkins,et al.  Modulation of tight junction structure and function by cytokines. , 2000, Advanced drug delivery reviews.

[16]  S. Tsukita,et al.  Endothelial Claudin , 1999, The Journal of cell biology.

[17]  Y. Ip,et al.  Snail/slug family of repressors: slowly going into the fast lane of development and cancer. , 2000, Gene.

[18]  T. Schöneberg,et al.  The specific fates of tight junction proteins in apoptotic epithelial cells , 2004, Journal of Cell Science.

[19]  J. M. Mullin,et al.  Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis. , 1997, The Journal of experimental zoology.

[20]  M. Osanai,et al.  Retinoid X Receptor α and Retinoic Acid Receptor γ Mediate Expression of Genes Encoding Tight-Junction Proteins and Barrier Function in F9 Cells during Visceral Endodermal Differentiation , 2001 .

[21]  B. Engelhardt,et al.  Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme , 2003, Acta Neuropathologica.

[22]  J. Reyes,et al.  The renal segmental distribution of claudins changes with development. , 2002, Kidney international.

[23]  J. McKenney,et al.  Expression of Claudin-1, a Recently Described Tight Junction-Associated Protein, Distinguishes Soft Tissue Perineurioma From Potential Mimics , 2002, The American journal of surgical pathology.

[24]  M. Kubbies,et al.  Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids , 2004, International journal of cancer.

[25]  S. Hosier,et al.  SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily. , 1999, Gene.

[26]  R. Miller,et al.  Increased tight junctional permeability is associated with the development of colon cancer. , 1999, Carcinogenesis.

[27]  N. Niikawa,et al.  Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. , 2001, Oncology research.

[28]  M. Osanai,et al.  Hepatocyte nuclear factor (HNF)-4α triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells , 2003 .

[29]  Takeshi Iwamura,et al.  Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. , 2003, Cancer research.

[30]  M. Kubbies,et al.  Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer , 2000, Human Genetics.

[31]  R. Kucherlapati,et al.  Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome. , 1997, Genomics.

[32]  B. Hillenbrand,et al.  Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity. , 2004, Biochemical and biophysical research communications.

[33]  A. Folpe,et al.  Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultrastructural correlation , 2004, Modern Pathology.

[34]  Christine A Iacobuzio-Donahue,et al.  Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. , 2004, American journal of clinical pathology.

[35]  M. Matsuda,et al.  A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells , 2004, Journal of Cell Science.

[36]  C. Marano,et al.  Modification of tight junction function by protein kinase C isoforms. , 2000, Advanced drug delivery reviews.

[37]  Shijiang Lu,et al.  Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays. , 2003, Carcinogenesis.

[38]  T. Yamashita,et al.  Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. , 2003, Experimental cell research.

[39]  I. Wada,et al.  Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. , 2003, Experimental cell research.

[40]  G. Riggins,et al.  Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. , 2000, Cancer research.

[41]  A. Hopkins,et al.  Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms 1 , 2003, The Journal of Immunology.

[42]  Shoichiro Tsukita,et al.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail , 2003, Journal of Cell Science.

[43]  M. Osanai,et al.  Tight junctions and human diseases , 2003, Medical Electron Microscopy.

[44]  J. Cameron,et al.  Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. , 2004, The American journal of pathology.

[45]  S. Tsukita,et al.  Conversion of Zonulae Occludentes from Tight to Leaky Strand Type by Introducing Claudin-2 into Madin-Darby Canine Kidney I Cells , 2001, The Journal of cell biology.

[46]  P. Nava,et al.  Tight junction proteins. , 2003, Progress in biophysics and molecular biology.

[47]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[48]  M. Löhr,et al.  Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. , 2001, Gastroenterology.

[49]  Kazushi Fujimoto,et al.  Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.

[50]  J. M. Mullin,et al.  Comparison of three integral tight junction barrier proteins in Barrett's epithelium versus normal esophageal epithelium. , 2003 .

[51]  Karl Matter,et al.  Signalling to and from tight junctions , 2003, Nature Reviews Molecular Cell Biology.

[52]  S. Liebner,et al.  Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme , 2000, Acta Neuropathologica.

[53]  D. Goodenough,et al.  Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. , 2000, Molecular biology of the cell.

[54]  T. Schöneberg,et al.  The Fate of Desmosomal Proteins in Apoptotic Cells* , 2001, The Journal of Biological Chemistry.

[55]  P. Argani,et al.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast , 2003, Oncogene.

[56]  R. Egleton,et al.  Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFκB , 2003, Journal of Cell Science.

[57]  E. Knust,et al.  Composition and Formation of Intercellular Junctions in Epithelial Cells , 2002, Science.

[58]  J. M. Mullin.  Epithelial Barriers, Compartmentation, and Cancer , 2004, Science's STKE.